X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9934) 9934
Book Chapter (49) 49
Magazine Article (16) 16
Book / eBook (9) 9
Dissertation (7) 7
Reference (5) 5
Newsletter (4) 4
Conference Proceeding (2) 2
Book Review (1) 1
Newspaper Article (1) 1
Streaming Video (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7485) 7485
dyslipidemia (4965) 4965
male (4657) 4657
female (4126) 4126
dyslipidemias - drug therapy (3437) 3437
middle aged (3369) 3369
risk factors (3331) 3331
cholesterol (2507) 2507
adult (2361) 2361
aged (2344) 2344
lipids (1861) 1861
dyslipidemias - blood (1679) 1679
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (1629) 1629
diabetes (1623) 1623
statins (1542) 1542
animals (1540) 1540
treatment outcome (1437) 1437
dyslipidemias - complications (1419) 1419
cardiovascular disease (1410) 1410
atherosclerosis (1397) 1397
hypertension (1362) 1362
pharmacology & pharmacy (1330) 1330
cardiac & cardiovascular systems (1329) 1329
hypolipidemic agents - therapeutic use (1325) 1325
coronary-heart-disease (1261) 1261
metabolic syndrome (1260) 1260
cholesterol, ldl - blood (1249) 1249
cardiovascular diseases (1234) 1234
risk (1202) 1202
lipids - blood (1177) 1177
obesity (1158) 1158
dyslipidemias - epidemiology (1117) 1117
insulin resistance (1116) 1116
cardiovascular diseases - prevention & control (1085) 1085
research (1076) 1076
cardiovascular-disease (1071) 1071
diabetes mellitus (1043) 1043
prevalence (1028) 1028
triglycerides - blood (1011) 1011
care and treatment (971) 971
triglycerides (970) 970
endocrinology & metabolism (967) 967
lipoproteins (920) 920
prevention (919) 919
cholesterol, hdl - blood (893) 893
health aspects (884) 884
dyslipidemias (869) 869
insulin-resistance (864) 864
mortality (853) 853
medicine, general & internal (815) 815
biomarkers - blood (805) 805
disease (791) 791
drug therapy (789) 789
low density lipoproteins (777) 777
metabolism (753) 753
cardiovascular diseases - etiology (746) 746
inflammation (720) 720
peripheral vascular disease (715) 715
analysis (703) 703
cholesterol - blood (697) 697
cardiovascular (688) 688
risk-factors (681) 681
atorvastatin (680) 680
type 2 diabetes (678) 678
body mass index (659) 659
drug therapy, combination (657) 657
therapy (654) 654
glucose (642) 642
time factors (624) 624
risk assessment (622) 622
cross-sectional studies (621) 621
hypercholesterolemia (613) 613
retrospective studies (601) 601
dyslipidemias - diagnosis (595) 595
blood pressure (594) 594
density-lipoprotein cholesterol (581) 581
dyslipidemias - metabolism (581) 581
cardiovascular diseases - epidemiology (579) 579
adolescent (576) 576
management (570) 570
insulin (566) 566
medicine & public health (564) 564
diabetes mellitus, type 2 - drug therapy (560) 560
medicine (558) 558
biochemistry & molecular biology (557) 557
anticholesteremic agents - therapeutic use (552) 552
myocardial-infarction (544) 544
hypertension - drug therapy (542) 542
internal medicine (539) 539
aged, 80 and over (536) 536
oxidative stress (534) 534
mice (531) 531
patients (527) 527
rats (526) 526
physiological aspects (523) 523
diet (521) 521
young adult (521) 521
comorbidity (516) 516
dyslipidemias - etiology (507) 507
diabetes mellitus, type 2 - complications (504) 504
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9479) 9479
Spanish (171) 171
Russian (87) 87
Japanese (78) 78
French (75) 75
German (36) 36
Portuguese (35) 35
Czech (26) 26
Chinese (25) 25
Polish (24) 24
Italian (20) 20
Hungarian (16) 16
Korean (10) 10
Croatian (6) 6
Romanian (4) 4
Turkish (4) 4
Lithuanian (3) 3
Swedish (3) 3
Arabic (2) 2
Danish (2) 2
Dutch (2) 2
Finnish (2) 2
Slovak (2) 2
Ukrainian (2) 2
Norwegian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Atherosclerosis, ISSN 0021-9150, 2016, Volume 246, pp. 243 - 250
.... The aim of this survey was to assess how statins were prescribed in CHD patients at discharge after a coronary event from hospitals throughout Europe and how the intake of these drugs was reported... 
Cardiovascular | LDL-Cholesterol | EUROASPIRE | Secondary prevention | Non-HDL-Cholesterol | Coronary heart disease | Statins | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | LDL CHOLESTEROL | PERCEPTION | DENSITY-LIPOPROTEIN CHOLESTEROL | STATIN THERAPY | PREDICTORS | PERIPHERAL VASCULAR DISEASE | HDL-CHOLESTEROL | DYSLIPIDEMIA | PRIMARY PREVENTION | CARDIOVASCULAR RISK-FACTORS | Secondary Prevention - trends | Humans | Middle Aged | Patient Discharge | Coronary Disease - epidemiology | Male | Drug Utilization Review | Young Adult | Dyslipidemias - blood | Time Factors | Guideline Adherence - trends | Lipids - blood | Aged, 80 and over | Adult | Female | Drug Therapy, Combination | Dyslipidemias - diagnosis | Coronary Disease - blood | Dyslipidemias - drug therapy | Cross-Sectional Studies | Risk Assessment | Risk Factors | Europe - epidemiology | Treatment Outcome | Biomarkers - blood | Coronary Disease - diagnosis | Drug Prescriptions | Practice Patterns, Physicians' - trends | Dyslipidemias - epidemiology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Adolescent | Coronary Disease - drug therapy | Aged | Healthcare Disparities - trends | Health Care Surveys | Practice Guidelines as Topic | Surveys | Medical research | Blood cholesterol | Cardiac patients | Low density lipoproteins | Mortality | Medicine, Experimental | Cardiovascular agents
Journal Article
Cell, ISSN 0092-8674, 10/2016, Volume 167, Issue 3, pp. 843 - 857.e14
Journal Article
Nature (London), ISSN 1476-4687, 2013, Volume 503, Issue 7477, pp. 493 - 499
Adiponectin secreted from adipocytes binds to adiponectin receptors AdipoR1 and AdipoR2, and exerts antidiabetic effects via activation of AMPK and PPAR-alpha... 
CRUCIAL ROLE | SKELETAL-MUSCLE | ACTIVATED PROTEIN-KINASE | FATTY-ACID OXIDATION | INSULIN-RESISTANCE | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | DISEASE | MECHANISMS | ADIPONECTIN LEVELS | EXPRESSION | Liver - pathology | Obesity - drug therapy | Longevity - drug effects | Adipose Tissue, White - metabolism | Receptors, Adiponectin - metabolism | Diabetes Mellitus, Type 2 - metabolism | Muscle Fibers, Skeletal - drug effects | Obesity - genetics | Glucose Intolerance - drug therapy | Liver - drug effects | Piperidines - pharmacology | Inflammation - drug therapy | Adenylate Kinase - metabolism | Diet, High-Fat | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | Receptors, Adiponectin - agonists | Adiponectin - metabolism | Drug Evaluation, Preclinical | Diabetes Mellitus, Type 2 - complications | Adipose Tissue, White - pathology | Adiponectin - pharmacology | Dyslipidemias - drug therapy | Piperidines - administration & dosage | Administration, Oral | Obesity - complications | Piperidines - metabolism | Liver - metabolism | Diabetes Mellitus, Type 2 - prevention & control | Insulin Resistance | Obesity - physiopathology | Transcription Factors - biosynthesis | Mitochondria - metabolism | Mitochondria - drug effects | Enzyme Activation - drug effects | Triglycerides - metabolism | Small Molecule Libraries - chemistry | Receptors, Adiponectin - deficiency | Animals | Signal Transduction - drug effects | Piperidines - therapeutic use | Muscle Fibers, Skeletal - cytology | Mice | Oxidative Stress - drug effects | PPAR alpha - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Adipose Tissue, White - drug effects | Receptors, Adiponectin - genetics | Muscles - cytology | Obesity | Insulin resistance | Muscular system | Kinases | Rodents
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 05/2014, Volume 311, Issue 18, pp. 1870 - 1882
Journal Article
Circulation, ISSN 0009-7322, 04/2007, Volume 115, Issue 14, pp. 1948 - 1967
Despite compliance with lifestyle recommendations, some children and adolescents with high-risk hyperlipidemia will require lipid-lowering drug therapy, particularly those with familial hypercholesterolemia... 
Drugs | Pediatrics | Lipids | Hypercholesterolemia | AHA Scientific Statements | FACTOR INTERVENTION PROJECT | INTIMA-MEDIA THICKNESS | DEPENDENT DIABETES-MELLITUS | lipids | CARDIAC & CARDIOVASCULAR SYSTEMS | LOW-CHOLESTEROL DIET | drugs | LOW-DENSITY-LIPOPROTEIN | RESTORES ENDOTHELIAL FUNCTION | BODY-FAT DISTRIBUTION | hypercholesterolemia | BLOOD-PRESSURE | pediatrics | HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA | PERIPHERAL VASCULAR DISEASE | LOW-SATURATED-FAT | Dyslipidemias - complications | Humans | Hyperlipoproteinemias - epidemiology | Middle Aged | Child, Preschool | Male | Arteriosclerosis - epidemiology | Phytotherapy | Child | Dyslipidemias - diagnosis | Metabolic Syndrome - epidemiology | Arteriosclerosis - etiology | HIV Protease Inhibitors - adverse effects | Hypolipidemic Agents - adverse effects | Arteriosclerosis - diagnostic imaging | Risk Factors | Combined Modality Therapy | Disease Progression | Arteriosclerosis - prevention & control | Diet, Fat-Restricted | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Hyperlipoproteinemia Type II - diet therapy | Adolescent | Age of Onset | HIV Infections - complications | Hypolipidemic Agents - therapeutic use | Arteriosclerosis - pathology | Cholesterol, Dietary | Dyslipidemias - diet therapy | Hyperlipoproteinemias - classification | Age Factors | Hyperlipoproteinemia Type II - diagnosis | Infant | Exercise Therapy | Contraindications | Dietary Fats | Hyperlipoproteinemias - drug therapy | Ultrasonography | Diabetes Complications - epidemiology | Adult | Cholesterol, LDL - blood | Female | Anticholesteremic Agents - classification | Hyperlipoproteinemia Type II - drug therapy | Hyperlipoproteinemia Type II - complications | Dyslipidemias - drug therapy | Clinical Trials as Topic | Anticholesteremic Agents - therapeutic use | Hyperlipoproteinemia Type II - epidemiology | Obesity - epidemiology | Hypolipidemic Agents - administration & dosage | HIV Infections - drug therapy | Hyperlipoproteinemias - genetics | Care and treatment | Demographic aspects | Hyperlipidemia | Research | Drug therapy | Risk factors
Journal Article
Mayo Clinic Proceedings, ISSN 0025-6196, 2014, Volume 89, Issue 1, pp. 25 - 33
Journal Article
Journal of lipid research, ISSN 0022-2275, 2016, Volume 57, Issue 9, pp. 1612 - 1618
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2010, Volume 363, Issue 3, pp. 233 - 244
Journal Article